PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY APPLICATION • Segmentation by application • Comparison by application • Global pathology instruments market by diagnostics • Global pathology instruments market by drug discovery • Global pathology instruments market by others • Market opportunity by application PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Pathology instruments market in Americas • Pathology instruments market in EMEA • Pathology instruments market in APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increasing product promotion activities • Government initiatives supporting molecular research • Increasing applications of digital pathology PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • Agilent Technologies • Danaher • F. Hoffmann-La Roche • PerkinElmer • Thermo Fisher Scientific PART 15: APPENDIX • List of abbreviations Exhibit 01: Related market Exhibit 02: Market characteristics Exhibit 03: Market segments Exhibit 04: Market definition - Inclusions and exclusions checklist Exhibit 05: Market size 2017 Exhibit 06: Validation techniques employed for market sizing 2017 Exhibit 07: Global pathology instruments market – Market size and forecast 2017-2022 ($ mn) Exhibit 08: Global pathology instruments market – Year over year growth 2018-2022 (%) Exhibit 09: Five forces analysis 2017 Exhibit 10: Five forces analysis 2022 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2017-2022 Exhibit 17: Global pathology instruments market by application – Market share 2017-2022 (%) Exhibit 18: Comparison by application Exhibit 19: Global pathology instruments market by diagnostics – Market size and forecast 2017-2022 ($ mn) Exhibit 20: Global pathology instruments market by diagnostics – Year over year growth 2018-2022 (%) Exhibit 21: Global pathology instruments market by drug discovery – Market size and forecast 2017-2022 ($ mn) Exhibit 22: Global pathology instruments market by drug discovery – Year over year growth 2018-2022 (%) Exhibit 23: Global pathology instruments market by others – Market size and forecast 2017-2022 ($ mn) Exhibit 24: Global pathology instruments market by others – Year over year growth 2018-2022 (%) Exhibit 25: Market opportunity by application Exhibit 26: Customer landscape Exhibit 27: Global pathology instruments market by region – Market share 2017-2022 (%) Exhibit 28: Regional comparison Exhibit 29: Pathology instruments market in Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 30: Pathology instruments market in Americas – Year over year growth 2018-2022 (%) Exhibit 31: Top three countries in Americas Exhibit 32: Pathology instruments market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 33: Pathology instruments market in EMEA – Year over year growth 2018-2022 (%) Exhibit 34: Top three countries in EMEA Exhibit 35: Pathology instruments market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 36: Pathology instruments market in APAC – Year over year growth 2018-2022 (%) Exhibit 37: Top three countries in APAC Exhibit 38: Market opportunity Exhibit 39: List of companion diagnostic tests and associated pathology instruments Exhibit 40: Advantages of FISH in detection of foodborne pathogens as compared with conventional methods Exhibit 41: Digital engagement index of key vendors Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Vendor overview Exhibit 48: Abbott – Business segments Exhibit 49: Abbott – Organizational developments Exhibit 50: Abbott – Geographic focus Exhibit 51: Abbott – Segment focus Exhibit 52: Abbott – Key offerings Exhibit 53: Agilent Technologies overview Exhibit 54: Agilent Technologies – Business segments Exhibit 55: Agilent Technologies – Organizational developments Exhibit 56: Agilent Technologies – Geographic focus Exhibit 57: Agilent Technologies – Segment focus Exhibit 58: Agilent Technologies – Key offerings Exhibit 59: Danaher overview Exhibit 60: Danaher – Business segments Exhibit 61: Danaher – Organizational developments Exhibit 62: Danaher – Geographic focus Exhibit 63: Danaher – Segment focus Exhibit 64: Danaher – Key offerings Exhibit 65: F. Hoffmann-La Roche overview Exhibit 66: F. Hoffmann-La Roche – Business segments Exhibit 67: F. Hoffmann-La Roche – Organizational developments Exhibit 68: F. Hoffmann-La Roche – Geographic focus Exhibit 69: F. Hoffmann-La Roche – Segment focus Exhibit 70: F. Hoffmann-La Roche – Key offerings Exhibit 71: PerkinElmer overview Exhibit 72: PerkinElmer – Business segments Exhibit 73: PerkinElmer – Organizational developments Exhibit 74: PerkinElmer – Geographic focus Exhibit 75: PerkinElmer – Segment focus Exhibit 76: PerkinElmer – Key offerings Exhibit 77: Vendor overview Exhibit 78: Thermo Fisher Scientific – Business segments Exhibit 79: Thermo Fisher Scientific – Organizational developments Exhibit 80: Thermo Fisher Scientific – Geographic focus Exhibit 81: Thermo Fisher Scientific – Segment focus Exhibit 82: Thermo Fisher Scientific – Key offerings

Abbott, Agilent Technologies, Danaher, F. Hoffmann-La Roche, PerkinElmer, and Thermo Fisher Scientific.